| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/27/2008 | WO2007150011A3 Prolyl hydroxylase inhibitors |
| 03/27/2008 | WO2007117381A9 2 -aminopyridine analogs as glucokinase activators |
| 03/27/2008 | WO2007092879A3 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 03/27/2008 | US20080076921 Inhibitors of bruton's tyrosine kinase |
| 03/27/2008 | US20080076917 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof |
| 03/27/2008 | US20080076781 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety |
| 03/27/2008 | US20080076776 Therapeutic compounds |
| 03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 03/27/2008 | US20080076774 Kinase Modulators and Methods of Use |
| 03/27/2008 | US20080076773 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt |
| 03/27/2008 | US20080076755 4-(Adamantane-1-carbonylamino)-3-oxo-2-aza-bicyclo[2.2.2]octane; 5-(Adamantane-1-carbonylamino)-10-oxo-9-aza-bicyclo[3.3.2]decane for treating autoimmune diseases, vascular disorders, viral infection or replication, asthma, osteoporosis, tumor growth, rheumatoid arthritis, organ transplant rejection |
| 03/27/2008 | US20080076754 Substituted spiroheterocycles |
| 03/27/2008 | US20080076753 Substituted spiroheterocycles |
| 03/27/2008 | US20080076748 Palladium 31-oxo-15- methoxycarbonylmethyl- Rhodobacteriochlorin-131-(2-N3- trimethylammoniumethyl)amide acetate (salt); bacteriochlorophylls free of carbamate group; as photosensitizer for thermodynamic therapy and diagnosis; cancer, age related macular degeneration; killing viruses and bacteria |
| 03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
| 03/27/2008 | DE102006043443A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 03/27/2008 | CA2665851A1 Spiro benzazepines as vasopressin antagonists |
| 03/27/2008 | CA2665849A1 Spiro benzazepines used as vasopressin antagonists |
| 03/27/2008 | CA2663791A1 Pyrazolo (1, 5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 03/27/2008 | CA2662835A1 Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents |
| 03/26/2008 | EP1903045A1 Pyrazolopyrimidine derivative |
| 03/26/2008 | EP1902716A1 Prophylactic and/or therapeutic agent for motor disorder |
| 03/26/2008 | EP1902057A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 03/26/2008 | EP1902056A2 Raf inhibitor compounds and methods of use thereof |
| 03/26/2008 | EP1902055A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | CN100377004C Image forming material and ammonium compound |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376580C Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376576C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/25/2008 | US7348429 Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process |
| 03/25/2008 | US7348343 N-(N-heteroaryl)1-pyridyl- or -pyrimidyl-hydropyridine-4-carboxamides; e.g., 3'-Chloro-3,6-dihydro-2H-[1,2']bipyridinyl-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide and 1-pyrimidin-2-yl-1,2,3,6-tetrahydro-pyridine-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide |
| 03/25/2008 | US7348338 PPAR active compounds |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348325 Pyrrolotriazine kinase inhibitors |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348323 [5-(4-cyclopentyl-piperazin-1-yl)-1H-pyrrolo[2,3-c]pyridin-2-yl]-pyrrolidin-1-yl-methanone; antagonists or inverse agonists at histamine 3 receptor; obesity, antidepressant, dementia and cognitive disorders, neurological disorders |
| 03/25/2008 | US7348321 Flumazenil for the treatment of alcohol dependency |
| 03/25/2008 | CA2173319C Radiation sensitization using texaphyrins |
| 03/20/2008 | WO2008033960A2 Systems and methods for transferring funds from a sending account |
| 03/20/2008 | WO2008033798A2 A pyrrolopyrazin as syk-kinase inhibitor |
| 03/20/2008 | WO2008033468A2 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | WO2008033447A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032060A1 4-benzimidaz0lyl-6-m0rph0lin0-2-piperazinylpyrimidine derivatives as p13k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032033A1 4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008031513A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | WO2008014108A3 Antimicrobial oxazolidinone prodrugs |
| 03/20/2008 | WO2008004698A3 Pyrazolo [1, 5-a] pyrimidine compounds as cb1 receptor antagonist |
| 03/20/2008 | WO2007146615A3 Long lived anion-selective sensors based on a covalently attached metalloporphyrin as anion receptor |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | WO2001003644A3 Pyrazolopyrimidinone derivatives conjugated to thiophene moieties or benzo [fused] 5-membered heterocycles for erectile dysfunction |
| 03/20/2008 | US20080071093 Forming, purification of dipyrromethane and porphrin ; condensation, oxidation, cyclization |
| 03/20/2008 | US20080071092 Oxidation color dye; reavcting a hydrazine compound |
| 03/20/2008 | US20080070941 Derivatives of n-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics |
| 03/20/2008 | US20080070936 Compounds specific to adenosine A1 receptors and uses thereof |
| 03/20/2008 | US20080070932 unexpectedly potent antagonists of A2a adenosine receptor; Parkinson's; neurodegenerative diseases; 2-furan-2-yl-N5-[1-(5-methyl-isoxazol-3-ylmethyl)-pyrrolidin-2-ylmethyl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070893 Cancer, neurological disorders, autoimmune disorders; inhibitors of CK2, a serine/threonine kinase; based upon macrocyclic pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine compounds |
| 03/20/2008 | US20080070891 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 03/20/2008 | US20080070889 Spirocyclic azetidin(one); e.g. 2,7-diazaspiro[3.5]nonan-1-one; T-type calcium channel blockers; Niemann-Pick C1-like (NPC1L1) antagonists |
| 03/20/2008 | US20080069817 Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
| 03/20/2008 | DE102006040915A1 New oxindole derivatives useful for treating vasopressin- or oxytocin-dependent diseases |
| 03/20/2008 | CA2663947A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663504A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663297A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1899350A1 Pyrazolo ý3 , 4-d¨azepine derivatives as histamine h3 antagonists |
| 03/19/2008 | EP1899349A1 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates |
| 03/19/2008 | EP1899348A1 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 03/19/2008 | EP1899347A2 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates |
| 03/19/2008 | EP1899346A1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 03/19/2008 | EP1899345A1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 03/19/2008 | EP1899344A1 Compounds that maintain pluripotency of embryonic stem cells |
| 03/19/2008 | EP1899343A1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates |
| 03/19/2008 | EP1899342A1 [1, 2, 4]triazolo [1, 5-a]pyrimidine derivatives as chromatographic adsorbent for the selctive adsorption of igg |
| 03/19/2008 | EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1711174B1 Adjuvant compositions |
| 03/19/2008 | EP1638966B1 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO ¬3,4-d PYRIMIDINE AND USES THEREOF |
| 03/19/2008 | EP1628979B1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 03/19/2008 | EP1581535B9 Pyrrolopyridazine derivatives |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1511751B1 Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents |
| 03/19/2008 | EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | CN101147286A Electrode for use in oxygen reduction |
| 03/19/2008 | CN101146889A Luminous compound containing lanthanide ion |
| 03/19/2008 | CN101146812A Optically active ammonium salt compound, production intermediate thereof and method for producing same |
| 03/19/2008 | CN101146811A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/19/2008 | CN101146540A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/19/2008 | CN101143866A Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |